Ogsiveotm (nirogacestat)

Gamma secretase inhibitor OGSIVEO is prescribed for adult patients with desmoid tumours that are growing and need systemic therapy.

Recommended Dosage:

150 mg taken twice a day is the suggested dosage until the condition progresses or the toxicity becomes intolerable.

Diarrhea: OGSIVEO might cause severe diarrhea. Doctors keep an eye on it and change the dose if it’s really bad.Ovarian

 Toxicity: This medicine might affect how a woman’s body works. Before treatment, doctors tell women about the possible risks, especially if they plan to have kids. They check regularly to make sure everything’s okay.

Hepatotoxicity: Some people might get higher AST and ALT levels in their blood. Doctors check these regularly and adjust the dose if needed.

Non-Melanoma Skin Cancers: Before starting OGSIVEO and while using it, doctors look at the skin to make sure there aren’t any unusual changes.

Electrolyte Abnormalities: OGSIVEO might change phosphate and potassium levels in the body. Doctors check these levels often and adjust the dose as needed.

Embryo-Fetal Toxicity: This medicine might harm an unborn baby. Doctors talk to patients about this risk if they might have a baby and advise them to use effective birth control.

If you are considering the import of Ogsiveotm (nirogacestat)  to India, please be aware that Ogsiveotm can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:

Required Documentation for Import:

• A valid prescription from a qualified medical practitioner.
  
• Diagnostic reports of the patient.
  
• Government-issued identification proof for the patient, as recognized by the Government of India.

The order for Ogsiveotm (nirogacestat) will be confirmed upon the receipt of the following documents:

• A valid prescription from a qualified doctor.
  
• An import permit, if applicable.

Ogsiveotm (nirogacestat) is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.

Ogsiveotm can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.

IPN (Indian Pharma Network) is dedicated to facilitating the supply of Ogsiveotm (nirogacestat) (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.

Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe.

Indian Pharma Network is proficient in sourcingOgsiveotm (nirogacestat)  from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient’s address, exclusively from New Delhi, India.

What is Nirogacestat?

Nirogacestat is an investigational medicine being studied for its potential in treating certain cancers. It belongs to a class of drugs called gamma-secretase inhibitors, aiming to block certain pathways in cancer cells.

What types of cancer is Nirogacestat being studied for?

Researchers are investigating Nirogacestat primarily for its potential in treating blood cancers like leukemia and lymphoma, as well as solid tumors such as certain types of breast and lung cancers.

How does Nirogacestat work?

Nirogacestat works by inhibiting a specific protein (gamma-secretase) involved in signaling pathways in cancer cells. By blocking these pathways, it aims to impede cancer cell growth and survival.

What stage of development is Nirogacestat currently in?

Nirogacestat is currently in clinical trials, which are research studies involving people, to evaluate its safety, effectiveness, and potential side effects in treating various types of cancers.

Is Nirogacestat available for use or treatment outside of clinical trials?

As of now, Nirogacestat is not approved for regular clinical use. It’s still under investigation in clinical trials and not yet available as a standard treatment. Participation in clinical trials is typically the way individuals can access investigational drugs like Nirogacestat.